Ignite Creation Date:
2024-05-06 @ 6:46 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05787587
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2023-03-17
Brief Title:
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Sponsor:
IDEAYA Biosciences
Organization:
IDEAYA Biosciences
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Prostate Cancer |
| Advanced or Metastatic Solid Tumors |
| Breast Cancer |
| Ovarian Cancer |
| Pancreas Cancer |
Keywords:
| Name | View |
|---|---|
| PARPi | View |
| PARP inhibitor | View |
| Advanced solid tumors | View |
| Metastatic solid tumors | View |
| BRCA 1 | View |
| BRCA 2 | View |
| BRIP1 | View |
| CDK12 | View |
| PALB2 | View |
| PPP2R2A | View |
| RAD51C | View |
| NBN | View |
| BRCA | View |
| HRD gene alteration | View |
| Breast | View |
| Ovarian | View |
| Homologous recombination | View |
| PARG | View |
| PARG Inhibition | View |
| ATM | View |
| BARD1 | View |
| CHEK1 | View |
| CHEK2 | View |
| FANCL | View |
| RAD51D | View |
| RAD54L | View |
| HRD | View |
| FANCA | View |